Cross‐contamination versus outbreak: Pre‐xdr mycobacterial strains confirmed by whole‐genome sequencing

Abstract

Whole‐genome sequencing (WGS) is promising for the quality control of laboratory facil-ities for Mycobacterium tuberculosis (MTB) strains. We describe the clinical and laboratory character-istics of false positive versus true positive MTB cultures based on WGS, which were experienced in a real clinical setting. Strain harvest and DNA extraction from seven isolates from pre‐extensive drug‐resistant (pre‐XDR) TB patients transferred to the Korea University Ansan Hospital were per-formed, and epidemiologic links and clinical information, including the phenotypic drug susceptibility test (pDST), were investigated. WGS was performed using Ion GeneStudio with an ION530tm chip (average sequencing depth, ~100‐fold). In the phylogenetic tree, identical and different strains were distributed separately. Five of the seven isolates were identical; the remaining two isolates differed from the others. The images of the referred pre‐XDR‐TB patients with false positive MTB that were analyzed were of regions close to old TB scars. Further, the results of WGS gene mutation analysis for ethambutol, streptomycin, and fluoroquinolone resistance in all six patients were not concordant with the pDST results. WGS and clinical information were useful in differentiating laboratory cross‐contamination from true positive TB, thereby avoiding the unnecessary treatment of false positive patients and delay in treating true positive TB patients, with reliable genotypic drug resistance results.